150 related articles for article (PubMed ID: 10447770)
1. Interleukin-12-secreting fibroblasts are more efficient than free recombinant interleukin-12 in inducing the persistent resistance to Mycobacterium avium complex infection.
Kang BY; Chung SW; Lim YS; Kim EJ; Kim SH; Hwang SY; Kim TS
Immunology; 1999 Jul; 97(3):474-80. PubMed ID: 10447770
[TBL] [Abstract][Full Text] [Related]
2. Induction of persistent in vivo resistance to Mycobacterium avium infection in BALB/c mice injected with interleukin-18-secreting fibroblasts.
Chung SW; Choi SH; Kim TS
Vaccine; 2004 Jan; 22(3-4):398-406. PubMed ID: 14670321
[TBL] [Abstract][Full Text] [Related]
3. Induction of in vivo persistent anti-mycobacterial activity by interferon-gamma-secreting fibroblasts.
Kim TS; Chung SW; Kang BY; Choe YY; Hwang SY
Vaccine; 2000 Jan; 18(11-12):1067-73. PubMed ID: 10590327
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
Kim SH; Cho D; Kim TS
Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
[TBL] [Abstract][Full Text] [Related]
5. Efficient induction of an antigen-specific, T helper type 1 immune response by interleukin-12-secreting fibroblasts.
Kim TS; Kim KM; Shin BA; Hwang SY
Immunology; 2000 Jun; 100(2):203-8. PubMed ID: 10886396
[TBL] [Abstract][Full Text] [Related]
6. Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18.
Kim SH; Cho D; Kim TS
Immunology; 2001 Feb; 102(2):234-41. PubMed ID: 11260329
[TBL] [Abstract][Full Text] [Related]
7. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection.
Saunders BM; Zhan Y; Cheers C
Infect Immun; 1995 Oct; 63(10):4011-5. PubMed ID: 7558312
[TBL] [Abstract][Full Text] [Related]
8. Injection with interleukin-4-secreting fibroblasts efficiently induces T helper type 2 cell-dominated immune response.
Kim TS; Kim SH; Hwang SY
Vaccine; 2000 Jun; 18(25):2832-7. PubMed ID: 10812226
[TBL] [Abstract][Full Text] [Related]
9. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species.
Roach DR; Martin E; Bean AG; Rennick DM; Briscoe H; Britton WJ
Scand J Immunol; 2001; 54(1-2):163-70. PubMed ID: 11439163
[TBL] [Abstract][Full Text] [Related]
10. Role of Th1/Th17 balance regulated by T-bet in a mouse model of Mycobacterium avium complex disease.
Matsuyama M; Ishii Y; Yageta Y; Ohtsuka S; Ano S; Matsuno Y; Morishima Y; Yoh K; Takahashi S; Ogawa K; Hogaboam CM; Hizawa N
J Immunol; 2014 Feb; 192(4):1707-17. PubMed ID: 24446514
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice.
Biet F; Kremer L; Wolowczuk I; Delacre M; Locht C
Infect Immun; 2002 Dec; 70(12):6549-57. PubMed ID: 12438324
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.
Azouaou N; Petrofsky M; Young LS; Bermudez LE
Immunology; 1997 Jul; 91(3):414-20. PubMed ID: 9301531
[TBL] [Abstract][Full Text] [Related]
13. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
Silva RA; Pais TF; Appelberg R
J Immunol; 1998 Nov; 161(10):5578-85. PubMed ID: 9820535
[TBL] [Abstract][Full Text] [Related]
15. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Huang X; McClellan SA; Barrett RP
Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production.
Feng CG; Jankovic D; Kullberg M; Cheever A; Scanga CA; Hieny S; Caspar P; Yap GS; Sher A
J Immunol; 2005 Apr; 174(7):4185-92. PubMed ID: 15778379
[TBL] [Abstract][Full Text] [Related]
17. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection.
Martin E; Kamath AT; Briscoe H; Britton WJ
Immunology; 2003 Jun; 109(2):308-14. PubMed ID: 12757627
[TBL] [Abstract][Full Text] [Related]
18. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.
Olleros ML; Vesin D; Martinez-Soria E; Allenbach C; Tacchini-Cottier F; Pache JC; Marchal G; Rahman J; Fernández C; Izui S; Garcia I
Immunology; 2007 Nov; 122(3):350-61. PubMed ID: 17623032
[TBL] [Abstract][Full Text] [Related]
20. Th1 cytokines facilitate CD8-T-cell-mediated early resistance to infection with Mycobacterium tuberculosis in old mice.
Vesosky B; Flaherty DK; Turner J
Infect Immun; 2006 Jun; 74(6):3314-24. PubMed ID: 16714559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
